Impact of reduced restrictions on buprenorphine prescribing during COVID-19 among patients in a community-based treatment program

Background: Medications such as buprenorphine are considered the gold standard for the treatment of opioid use disorders. This study aimed to determine whether less restrictive buprenorphine prescribing practices during the COVID-19 pandemic impacted retention in and adherence to buprenorphine among...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Kathleen M. Ward, Ayden Scheim, Jonathan Wang, Benjamin Cocchiaro, Katie Singley, Alexis M. Roth
Formato: Artigo
Idioma:Inglês
Publicado em: Elsevier 2022-06-01
Colecção:Drug and Alcohol Dependence Reports
Assuntos:
Opioid use disorder
Retention
Adherence
People who use drugs
Buprenorphine
COVID-19
Acesso em linha:http://www.sciencedirect.com/science/article/pii/S2772724622000336
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados